Nutra Pharma Corp (NPHC) Non-Current Assets (2010 - 2026)

Nutra Pharma has disclosed Non-Current Assets across 17 years of filings, most recently posting $159744.0 for Q2 2026.

• In Q2 2026, Non-Current Assets fell 17.63% year-over-year to $159744.0; the TTM figure through Jun 2026 stood at $604603.0 (down 32.05% YoY), while the FY2025 annual figure was $163018.0, down 27.44% from the prior year.
• Non-Current Assets came in at $159744.0 for Q2 2026 at Nutra Pharma, up from $117094.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $421336.0 in Q4 2022 to a low of $117094.0 in Q1 2026.
• Average Non-Current Assets over 5 years is $260579.2, with a median of $249907.0 recorded in 2022.
• Year-over-year, Non-Current Assets jumped 71.14% in 2022 and sank 47.51% in 2026.
• Over 5 years, Non-Current Assets stood at $421336.0 in 2022, then fell by 22.55% to $326337.0 in 2023, then tumbled by 31.16% to $224658.0 in 2024, then retreated by 27.44% to $163018.0 in 2025, then dropped by 2.01% to $159744.0 in 2026.
• Per Business Quant data, the three most recent Non-Current Assets figures were $159744.0 in Q2 2026, $117094.0 in Q1 2026, and $163018.0 in Q4 2025.